Skip to main content
Caplight Logo









NovoLINC

NovoLINC

Private
Pittsburgh, PennsylvaniaFrontier & Industrial Techhttps://novolinc.com

Last Round

Seed

Dec 18, 2025

Total Funding Raised

$12.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

NovoLINC operates in Frontier & Industrial Tech and is based in Pittsburgh, Pennsylvania. Its latest recorded funding round was a Seed round in December 2025.

NovoLINC is a nanotechnology and manufacturing company that develops advanced thermal interface material solutions for high-performance computing.

Sector

Frontier & Industrial Tech

Verticals

Advanced Materials, Semiconductors, Computing Hardware

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

NovoLINC Comparables

Compare NovoLINC with similar companies based on industry and business-model similarity.

NovoLINC comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Arieca Inc.
86%
Carbice
80%
Boston Materials
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

NovoLINC Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 18, 2025
SeedJan 21, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

NovoLINC Investors

Notable investors and investment history

NovoLINC investors
InvestorRounds
HV FundSeed
Carnegie Mellon University Investment OfficeSeed
M VenturesSeed
Foothill VenturesSeed
TDK VenturesSeed
Fathom FundSeed
M VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 16, 2026

    Grew 17% QoQ, from 18 to 21 employees.

  • Jul 28, 2026

    Grew 29% QoQ, from 17 to 22 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • expands_facilitiesSep 18, 2026

    NovoLINC, Inc. expands to a new facility in Pennsylvania to meet rising demand.

  • launchesSep 17, 2026

    NovoLINC, Inc. launches MaxLINC, a thermal interface material for multi-kilowatt AI chips that achieves thermal resistance as low as 0.7 mm^2 - K/W, in Pennsylvania on Sep 17th '26.

  • expands_facilitiesSep 17, 2026

    NovoLINC, Inc. expands its Pittsburgh-area operations into a new facility in Pennsylvania, increasing capacity for manufacturing scale-up, product qualification and testing, and continued research and development.

Book a demo to see all news

For institutional investors. Book with your work email.

NovoLINC Filings

Explore SEC and related filing metadata, where available.

NovoLINC filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about NovoLINC's valuation, stock price, and market status.

Is NovoLINC a public or private company?

NovoLINC is a private company.

What is the current stock price of NovoLINC?

NovoLINC is a private company, so its shares have no public market price. Caplight tracks NovoLINC's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is NovoLINC worth (valuation)?

Valuation information for NovoLINC is not publicly available.

Can I buy NovoLINC stock?

NovoLINC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was NovoLINC's last funding round?

NovoLINC's most recent funding round was Seed on December 18, 2025.

Who are the main investors in NovoLINC?

Key investors in NovoLINC include M Ventures, TDK Ventures, Fathom Fund, M Ventures.

Will NovoLINC IPO soon?

No public IPO plans have been announced for NovoLINC.

How can I track NovoLINC secondary market activity?

Caplight tracks bids, offers, and trades in NovoLINC's shares on secondary markets.

Firmographic Details

HeadquartersPittsburgh, Pennsylvania
Employee Range17
Year Founded2024
Last FundingDec 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?